Musk, the billionaire SpaceX and Tesla CEO, took shots this week at Stargate, Trump's highly touted project, and its partners ...

Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

President Trump's massive $500 billion AI infrastructure dubbed Stargate rustled plenty of feathers, reigniting a bitter feud ...

In the latest development in the pair’s longtime feud, Elon Musk, a key White House advisor as well as the founder of AI ...

Stargate is little more than an extension of Sam Altman's powerful AI company, anonymous sources told the Financial Times.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

Musk’s criticisms have escalated into legal actions. In February, he filed a lawsuit against OpenAI, accusing it of breaching ...

Musk has raised questions on project Stargate, the $500bn AI project. This lead to a verbal spat between him and Sam Altman.

Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...

OpenAI CEO Sam Altman envisions a future where AI surpasses human intelligence, emphasizing that human skills will still hold ...